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Abstract: Long-term cancer survivors represent a sizeable portion of the population. Plant-based foods
may enhance the prevention of cancer-related outcomes in these patients. We aimed to synthesize
the current evidence regarding the impact of plant-based dietary patterns (PBDPs) on cancer-related
outcomes in the general population and in cancer survivors. Considered outcomes included overall
cancer mortality, cancer-specific mortality, and cancer recurrence. A rapid review was conducted,
whereby 2234 original articles related to the topic were identified via Pubmed/Medline. We selected
26 articles, which were classified into studies on PBDPs and cancer outcomes at pre-diagnosis:
vegan/vegetarian diet (N = 5), provegetarian diet (N = 2), Mediterranean diet (N = 13), and studies
considering the same at post-diagnosis (N = 6). Pooled estimates of the associations between the
aforementioned PBDPs and the different cancer outcomes were obtained by applying random effects
meta-analysis. The few studies available on the vegetarian diet failed to support its prevention potential
against overall cancer mortality when compared with a non-vegetarian diet (e.g., pooled hazard ratio
(HR) = 0.97; 95% confidence interval (CI): 0.88–1.06). The insufficient number of studies evaluating
provegetarian index scores in relation to cancer mortality did not permit a comprehensive assessment
of this association. The association between adherence to the Mediterranean diet and cancer mortality
reached statistical significance (e.g., pooled HR = 0.84; 95% CI: 0.79–0.89). However, no study
considered the influence of prognostic factors on the associations. In contrast, post-diagnostic
studies accounted for prognostic factors when assessing the chemoprevention potential of PBDPs,
but also were inconclusive due to the limited number of studies on well-defined plant-based diets.
Thus, whether plant-based diets before or after a cancer diagnosis prevent negative cancer-related
outcomes needs to be researched further, in order to define dietary guidelines for cancer survivors.
Keywords: cancer; mortality; survival; vegan; vegetarian; Mediterranean diet; diet quality;
plant-based food
1. Introduction
The latest global cancer statistics have reported that there were 17.0 million new cases of cancer
and 9.5 million cancer-related deaths (excluding non-melanoma skin cancer) in 2018 [1]. It is estimated
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that 43.8 million cancer patients who survived the disease for five years or more were alive in 2018, with
lung, breast, colorectal, prostate, and gastric cancer contributing more prominently to this number [2,3].
Data from Europe (EU-28) are also impressive, with more than 12.1 million prevalent cancer patients
in 2018 [3]. Parallel to the increase of the number of new cancer patients over the past decades,
the proportion of cancer survivors has also grown. Survival rates for cancer have increased steadily
for patients diagnosed with cancer from 1999 to 2007 [4]. This increased survival may be partially
attributed to improved diagnosis and treatments, better access to high-quality services and earlier
diagnosis [5]. However, several factors can lead to worse cancer prognosis, among which unhealthy
dietary choices warrant special consideration [6].
Plant-based food (fruits, vegetables, cereals, nuts and seeds, legumes, and vegetable oils) are
the main source of fiber and other bioactive compounds in the diet [7]. Particularly, plant bioactives
including fiber, sulfur compounds, carotenoids, and polyphenols, present in foods such as cruciferous
and allium vegetables, tomatoes, green tea, and whole grain cereal, have well-known anticarcinogenic
properties [7]. Plant-based foods are therefore likely to exert anti-inflammatory and anti-oxidative
effects against the development of cancer [7]. Thus, whereas an unhealthy diet is an established risk
factor for several cancer types, eating plant-based foods to achieve a healthful diet has been associated
with a reduced cancer risk according to the latest report on diet and cancer, released by the World
Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) [8].
A considerable number of studies examined the association between individual nutrients or foods
and cancer mortality [9,10]. Most of these studies have focused on associations between pre-diagnosis
dietary intake and cancer-related outcomes, while only a few studies have assessed how post-diagnosis
dietary intake affects these outcomes [11]. Moreover, nearly all have focused on overall cancer mortality,
whereas studies on cancer-specific mortality are scarce [11–14]. In addition to the above, findings from
these studies are far from conclusive. For example, inconsistent associations were reported between
fruit and vegetable consumption and cancer mortality in a meta-analysis of sixteen prospective
studies [15]. For other plant-based foods, including nuts [16] and legumes [9], strong associations with
cancer mortality have been observed. In contrast, olive oil consumption was not found to be associated
with cancer mortality in several studies [17,18]. Therefore, until now, there is no sufficient evidence to
recommend dietary factors for cancer mortality prevention.
Considering, the overall diet (i.e., the dietary pattern) is more appropriate in view of the
complex nature of the diet, and the interrelation between its constituents (foods and nutrients) [19].
Dietary patterns can be assessed using the conceptual framework of a dietary pattern (a priori), or
empirically (a posteriori), and allow to establish more robust associations than when considering
nutrients or foods on an individual basis [20]. It is also of great importance that dietary patterns,
especially a priori dietary patterns, are more suitable to derive dietary guidelines for the prevention
of cancer [8,21]. However, not much attention has been paid to the influence of diet as a whole on
cancer mortality outcomes. So far, the WCRF/AICR cancer prevention guidelines establish the same
recommendations for cancer survivors as for the general population. Adherence to these guidelines
by means of the WCRF/AICR 2007 score has been associated with a lower cancer mortality risk in
a meta-analysis combining only three studies on this association [14].
Thus, whether specific dietary guidelines reduce cancer mortality risk in the population (before the
diagnosis of cancer) or in cancer survivors (from post-diagnosis) remains unclear. Dietary guidelines
accounting for the holistic effects of plant-based foods within a healthy diet for preventing cancer
mortality are crucial in this regard. Their effects have been thoroughly examined for cancer
incidence [13,22], but not with respect to cancer mortality. Hence, the aim of this review was to
synthesize the current evidence regarding cancer mortality. For the purpose of this review, plant-based
dietary patterns (PBDPs) were deemed to be the vegetarian diet (VD) in all its variations and the
Mediterranean diet (MD). For the latter, we focused on a priori-derived MD indexes (e.g., the MD score,
the alternate MD index (aMED), and others, in their various versions), whereas empirically derived
a posteriori patterns were discarded. Furthermore, we distinguished between pre-diagnostic and
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post-diagnostic effects of PBDPs on cancer outcomes including overall cancer mortality, cancer-specific
mortality, and cancer recurrence.
2. Materials and Methods
A rapid review methodology was chosen to conduct the review in a timely manner,
following a pre-established protocol for systematic reviews (with the exception of several steps that
were omitted to speed up the process, such as methodological quality assessment), and according to
the general methodology of the Preferred Reporting Items of Systematic Reviews and Meta-Analyses
(PRISMA) guidelines [23–25]. Whenever possible, results extracted from the selected studies were
pooled in a meta-analysis. The steps are described in more detail below.
2.1. Search Strategy
Leading electronic databases (Medline via PubMed) were searched from 1999 (no studies were
available before) until 20 April 2020. The search strategy used (with a combination of Mesh terms,
keywords, and operators) is detailed in Appendix A. The flow diagram illustrating the process of
identifying and selecting studies is shown in Appendix B.
2.2. Study Eligibility Criteria
The review included all original studies in humans that provided data on cancer mortality or
survival in relation to PBDPs. These studies were intervention studies, cohort studies, and case-control
studies. Systematic reviews or meta-analyses were not eligible, but they were included in the search
to further retrieve original studies on the topic by manual search. The most updated reviews were
selected as references to encompass all the available studies [11,26–28]. Studies that were published
thereafter and those studies not included in these previous reviews were included too.
With reference to the outcomes, we considered studies the primary outcome of which was overall
and/or cancer-specific mortality, and studies reporting results on other related outcomes such as
recurrence and progression of the disease. Cancer survivors did not include survivors of cervical
lesions or adenomas in the colon since these are considered benign or non-malignant lesions according
to common histological classification of tumors. In addition, eligible studies were those evaluating
dietary patterns by questionnaire assessment.
PBDPs were defined as: (i) a diet excluding meat and meat products, flesh from any animal,
and seafood, or all foods of animal origin, in the strictest sense (vegetarian and vegan diet, respectively);
and (ii) a diet featuring a higher consumption of fruits, vegetables, legumes, and nuts over foods
of animal origin. We considered the vegetarian diet and Mediterranean diet (MD) as plant-based
dietary models. For the former, vegetarian population studies or studies that ascertained compliance
with the vegetarian diet standards were eligible. To establish the latter, only a priori-derived MD
indexes were included due to their high translational capacity into dietary prevention guidelines. In
the light of the different adaptations that have been applied to the first MD score (MDS) proposed by
Trichopoulou et al. [29,30], no restrictions were applied to these indexes.
All possible comparisons between vegetarians, vegans (or both combined) with respect to
omnivores or different combinations of vegetarianism (e.g., lacto-ovo vegetarians) were considered.
We also considered studies that established comparisons by levels of adherence to PBDPs.
Furthermore, studies assessing the association between PBDPs and cancer mortality both before
and after cancer diagnosis were included.
Studies conducted in children and adolescents (aged <18 years) were excluded, as were those
not reporting any risk estimate (odd ratio (OR), relative risk (RR), or hazard ratio (HR) and the
corresponding 95% confidence interval (CI)) on the association between dietary patterns and the
aforementioned cancer-related outcomes. Studies written in languages other than English or Spanish
were also excluded.
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2.3. Data Collection and Analysis
Selection of Studies
Studies were first screened by title and abstract by two reviewers (E.M.M. and E.S.F.) and the final
study selection was performed based on a full text review. When there were several articles reporting
results based on the same study population, we included the study reporting the most updated data.
Any discrepancies were resolved by consulting a third reviewer (M.J.S.).
2.4. Data Extraction and Management
Data extraction was performed by three reviewers (E.M.M., E.S.F., and B.G.V.) using a predefined
standardized form to collect information on: (a) study characteristics: authors and year(s),
study description and design, country, study population characteristics with regard to sample size,
gender, and age; (b) the assessment methods used to collect information on diet (questionnaires and
tools) and cancer-related outcomes (cancer registry or medical records data), also distinguishing between
pre- and post-diagnosis association studies; (c) the measured outcomes: overall cancer mortality,
cancer-specific mortality, and cancer recurrence; (d) the PBDPs under consideration (vegetarian,
Mediterranean, and their variations), type (population-based or a priori), and the comparison groups
(e.g., high vs. low adherence or vegetarians/vegans vs. omnivores); and (e) the reported results:
measures of effect size (OR, HR, and RR, with 95% CI) and confounding variables considered
for adjustment.
2.5. Presentation of Results
The results of all studies were presented in tabular format and summarized narratively by type of
dietary pattern and cancer-related outcome. To summarize these studies, we described their results
and risk estimates adjusted for all potential confounders. When possible, these results were pooled
in meta-analyses.
2.6. Meta-Analysis
We calculated the summary estimates (from log HR/RRs in cohort studies, for dichotomous
outcomes and comparisons between exposure groups) and corresponding 95% CIs when at least two
studies reported results on the same outcome, using random effects models to account for possible
heterogeneity between studies [31].
The Cochran Q test and I2 test statistic (assuming heterogeneity if I2 > 50%) were used to assess
heterogeneity between studies. Publication bias was assessed by Egger’s test and visual inspection of
the funnel plots [32,33]. A p-value of < 0.05 was deemed as statistically significant. The “metafor”
package in R version 3.6.3 (R software) was used for these analyses.
3. Results
A total of 2234 publications was identified. In addition, we considered the most up-to-date reviews
addressing the association between dietary patterns and cancer mortality [11–14]. These reviews
added 25 studies, not previously retrieved. Of these, 930 were excluded in the first step to retain
original articles published from 1999. Then, 1256 studies were excluded on the basis of title and
abstract, and 73 publications were reviewed using full text. Forty-seven publications were excluded
for not fulfilling the inclusion criteria (no cancer related outcomes = 19; not about dietary patterns
but single nutrient/food studies = 14; not an original study = 1; a posteriori indexes = 5; a priori but
not MD = 8). Thus, 26 studies were included in this review: 5 VD-like studies [34–38], 12 MD-like
studies [39–51], 2 provegetarian diet studies [52,53], and 6 post-diagnosis studies [54–59]. The study by
Key et al. was not included because no risk ratios on cancer mortality were reported [60]. Results are
presented in the following sections.
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3.1. Vegetarian and Vegan Diet
With reference to cancer mortality, characteristics of the studies evaluating VDs (vs. nonvegetarians)
and cancer mortality are shown in Table 1. These studies were based on large cohorts of known
vegetarians and vegans also including nonvegetarians/nonvegans, who were followed-up for different
outcomes including cancer mortality. Some of these cohorts were the Adventist Mortality Study,
the Adventist Health Studies, the Oxford and Heidelberg Vegetarian Studies, the European Prospective
Investigation into Cancer and Nutrition (EPIC) Oxford Vegetarian Study, and the Health Food Shoppers
Study, which were combined in some of the selected publications [35,38,55]. Some studies based the
VD assessment on questions regarding whether the participants followed a VD or not (e.g., Health
Food Shoppers study); on the reported consumption of meat or fish using close-ended questions
(e.g., Heidelberg study); or on dietary questionnaires aiming to identify non-consumers of meat or
fish (e.g., the Adventist Health Study). The studies by Orlich et al. and Key et al. [37,61] were based
on two different arms of the Adventist Health Study. Both were included to account for overall and
cancer-specific (colorectal) mortality. All studies assessed the association between vegetarian eating
habits and cancer mortality before cancer diagnosis (all excluded prevalent cancer cases at recruitment),
and all assessed cancer mortality and cause-specific mortality using national mortality registry data
(death certificates).
The study by Key et al. [34] compared death rates between vegetarians and nonvegetarians and
showed significant heterogeneity between the five included cohorts. This heterogeneity was probably
driven by the fact that the studied populations differed with regard to socio-demographic factors and
definitions of the vegetarian population groups. Risk estimates were adjusted for age, sex, and smoking,
despite the fact that smoking was not collected in some of the included cohorts. Unreliable associations
were reported by duration of vegetarianism due to the limited sample size. In addition, participants
were asked whether they considered themselves vegetarians, but no further dietary information was
collected. Two of the cohorts (the Oxford Vegetarian and Health Food Shoppers) were included in the
article by Appleby et al. [35]. Later on, Appleby et al. [38] compared vegetarian vs. nonvegetarian
dietary habits in relation to cancer mortality (overall and by cancer type) in some of these previous
cohorts (the Oxford Vegetarian and EPIC Oxford Study from the UK). This study also combined
vegans and vegetarians in the analyses but considered as a reference group, regular meat eaters (intake
>5/week). Importantly, low meat eaters (intake <5/week) and fish eaters (i.e., pesco-vegetarians) were
considered in separate categories. The latter study also adjusted for every possible confounding
variable related to medical history and lifestyle habits. The studies by Orlich [37,61] based the
assessment of vegetarian diet on the dietary information collected with a validated food frequency
questionnaire (FFQ) among 73,308 participants of the Adventist Health Cohort. Using this dietary data,
the authors were able to classify participants into vegans, lacto-ovo vegetarians, pesco-vegetarians,
semi-vegetarians, and nonvegetarians, according to the frequency of intake of particular animal foods
(eggs/dairy <1/month, fish >1/month, meats <1/week, and meats >1/week, respectively). This study
was, indeed, one of the few reporting risks associated with cancer mortality comparing different types
of vegetarians to nonvegetarians, as well as all kinds of vegetarians vs. nonvegetarians. No significant
associations were reported with respect to cancer mortality in any of these subgroups. Finally, the study
by Chang-Claude et al. [36], included 1225 vegetarians and 679 health-conscious nonvegetarians from
Germany, who provided dietary information on usual frequency of consumption of plant-based foods,
milk, eggs, fish, meat, and processed meat. Mortality ratios were compared for vegans and vegetarians,
while RRs associated with cancer mortality and adjusted for relevant confounders were reported for
vegetarians and vegans combined vs. nonvegetarians. None of these studies considered the influence
of cancer treatment or other prognostic factors on the associations.
Pooled estimates of effect sizes and 95% CIs for cancer mortality comparing vegetarians vs.
non-vegetarians are shown in Figure 1 and described below. Whenever possible, we removed
overlapping cohorts between the studies (e.g., those included in Key et al. (1999) and Appleby
(2002) [34,35]). There was no evidence for publication bias according to funnel plots and Egger tests.
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Table 1. Characteristics of the studies evaluating VD (vs. nonvegetarian diet) and cancer mortality including cause-specific cancer mortality.





















reported that they did not
eat any meat or fish;
non-vegetarians: all others
6/10,258 Lung 0.59 (0.10–3.28)
26/10,258 Breast 0.65 (0.28–1.52)








11.1 104/8003 CRC 1.01 (0.66–1.56)
1, 2, 3
NA
96/8003 Lung 0.69 (0.37–1.27)
64/8003 Breast 0.52 (0.27–0.97)








9.9 5/1083 CRC 0.35 (0.06–2.11) 1, 2, 3 NA
5/1083 Breast 1.09 (0.18–6.67)











156/4674 Overall 0.89 (0.72–1.10)
1, 2, 3
NA vegetarians: those who
reported that they did not
eat any meat or fish;
non-vegetarians: all others
25/4674 CRC 1.20 (0.68–2.13)
16/4674 Lung 0.82 (0.44–1.56)
22/4674 Breast 1.02 (0.57–1.84)










18.7 203/4600 Overall 1.12 (0.95–1.32)
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NA vegetarians: those who
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vegetarian?”
33/4600 CRC 0.79 (0.51–1.22)
24/4600 Lung 1.05 (0.64–1.72)
41/4600 Breast 1.73 (1.11–2.69)
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Table 1. Cont.
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M/F 5.9 706/73,308 Overall 0.90 (0.75–1.09)
2, 3, 4, 5, 6,




more than 200 food
items
vegan: eggs/dairy, fish, and meats
<1 month; lacto-ovo vegetarian:
eggs/dairy ≥1 month but fish and
meats <1 month; pesco-vegetarian:
fish ≥1 month but meats <1 month;
semi-vegetarians: non-fish meats ≥1
month and meats combined ≥1






UK Oxford Vegetarian Study (N =
52,659);
European Prospective
Investigation into Cancer and
Nutrition (EPIC) Oxford




>5 years 520/55,367 Overall 0.91 (0.80–1.03)
1, 2, 3, 4, 5,




or not they consumed
meat, fish, dairy
products, and eggs, and
two questions on the
frequency of meat
consumption
four diet groups: regular meat
eaters (eat meat on >5 times/w), low
meat eaters (eat meat <5 times/w),
fish eaters, and vegetarians and
vegans combined (non-meat and/or
fish eaters);
nonvegetarians: all others
76/55,367 CRC 1.11 (0.79–1.58)
20/55,367 Pancreas 0.44 (0.26–0.76)
62/55,367 Lung 1.07 (0.75–1.54)
70/55,367 Breast 1.12 (0.77–1.63)
41/55,367 Ovary 0.97 (0.61–1.52)
28/55,367 Hematolymphoid 0.47 (0.30–0.73)
RR = relative ratio; CI = confidence interval; F = females; M = males; FFQ = food frequency questionnaire; 24-HR = 24 h recall; CRC = colorectal cancer; NA = not available; n = number of
events; N = total population (or vegetarians). Adjustments: 1: sex; 2: sge; 3: smoking; 4: physical activity; 5: alcohol intake; 6: education; 7: body mass index (BMI); 8: race; 9: income; 10:
marital status; 11: region; 12: sleep; 13: hormone replacement therapy (HRT) use; 14: history of peptic ulcer and inflammatory bowel disease (IBD); 15: family history of colorectal cancer;
16: energy; 17: treatment for diabetes; 18: aspirin/statins; 19: supplemental Ca/vitamin D; 20: fiber; 21: colonoscopy; 22: supplements; 23: study/method of recruitment; 24: parity; 25: oral
contraceptive use; 26: HRT use; 27: diabetes; 28: blood pressure.
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Figure 1. Meta-analysis under random-effects model (REM) with regard to vegetarian diet (VD)
(vs. nonvegetarian diet) by subgroups of overall cancer mortality and cause-specific mortality. Q and
I2 statistics are indicated for each subgroup analysis together with the pooled estimate (rhombus).
3.1.1. Overall Cancer Mortality
Overall cancer mortality was evaluated in four articles [35–38], with one article reporting estimates
for two different cohorts [35]. The articles by Appleby [35,38] combined the study populations of
the Oxford Vegetarian Study, the Health Food Shoppers Study, and the EPIC Oxford Vegetarian
Study. While there seemed to be population overlap in the Oxford Vegetarian Study between the
articles [35,38], it was not possible to retrieve separate risk estimates by study populations. The overall
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analysis was based on 139,174 participants and 1661 cancer mortality events. The mean age of study
participants varied greatly between the studies (from 43 to 58 years), as well as the level of confounding
adjustment: from minimal by age, sex, and smoking adjustment [35] to full adjustments [36–38].
Pooled estimates showed that VD (vs. nonvegetarian) was not significantly associated with overall
cancer mortality (RR = 0.97; 95% CI: 0.88–1.06). There was no significant heterogeneity between the
studies (I2 = 30%, p = 0.24).
3.1.2. Breast Cancer Mortality
There were three articles on the association between VD and breast cancer mortality [34,35,38],
which together analyzed the association within six cohorts. Potential population overlap between the
Oxford Vegetarian Study cohorts could not be resolved. After pooling risk estimates, based on 228 breast
cancer events among 83,985 participants, a non-significant association was observed between VD
(vs. nonvegetarian) and breast cancer mortality (RR = 0.99; 95% CI: 0.67–1.44). Heterogeneity tended
to be significant and became less apparent after exclusion of the Heidelberg Study included in
Key et al. [34]. The association remained, however, nonsignificant (data not shown).
3.1.3. Colorectal Cancer Mortality
Three studies including six cohorts reporting results for 279 colorectal cancer events among
83,985 participants, evaluated the association between VD and colorectal cancer mortality [34,35,38,61].
Vegetarian diet (vs. nonvegetarian) compliance was not significantly associated with colorectal cancer
mortality after pooling risk estimates of these studies (RR = 1.03; 95% CI: 0.84–1.26). There was no
heterogeneity among the studies (I2 = 0%, p = 0.54).
3.1.4. Cancer Mortality for Other Cancer Types
Prostate and lung cancer mortality was evaluated in two [34,35] and three [34,35,38] articles,
respectively. Both showed nonsignificant associations in pooled analyses. Gastric cancer mortality
was also evaluated in two of the cohorts included in the study by Key et al. [34], but no consistent
associations were reported. For other cause-specific cancer mortality, only pancreas, ovary, and
lymphatic/hematopoietic cancers were evaluated in relation to VD in the study by Appleby et al. [38].
Interestingly, there was a significant inverse association of VD (vs. nonvegetarian) with pancreas cancer
mortality (RR = 0.44; 95% CI: 0.26–0.76) and lymphatic/hematopoietic cancer mortality (RR = 0.47;
95% CI: 0.30–0.73), but a nonsignificant association with ovarian cancer mortality. Low meat eaters vs.
regular meat eaters were also found to have lower pancreatic cancer mortality risk (RR = 0.54; 95% CI:
0.35–0.85) in this study.
3.2. Provegetarian Diets
Our literature search retrieved two studies on the association between provegetarian diets and
cancer mortality [52,53]. Characteristics of these studies are shown in Table 2.
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regard to all plant-based
foods (standard score), or
either healthy plant-based
foods (healthy score) or
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reversed for all other
animal-based foods.
F = females; M = males; FFQ = food frequency questionnaire; 24-HR = 24 h recall; CRC = colorectal cancer; NA = not available; n = number of events; N = total population. Adjustments: 1:
sex; 2: age; 3: smoking; 4: physical activity; 5: alcohol intake; 6: education; 7: BMI; 8: race; 9: energy intake; 10: use of aspirin and multivitamins; 11: family history of medical conditions;
12: menopausal status; 13: HRT use; 14: weight change; 15: medical history; 16: use of medication for hypertension and hypercholesterolemia.
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In the first study [52], conducted with 7216 elderly participants (mean age = 67 years) of the
Spanish PREDIMED (Prevención con Dieta Mediterránea) study, the authors assessed five levels
of adherence to a provegetarian diet score by considering fruits, vegetables, nuts, cereals, legumes,
olive oil, and potatoes as positive components, and animal fats, eggs, fish, dairy products, and meats
or meat products as negative components. As the authors showed, this score was not correlated
with the traditional MD score, supporting that both scores capture different dietary dimensions of
a plant-based diet. This study used dietary data obtained through a validated 137-item FFQ, which
was administered yearly during the follow-up. The outcome (death) was assessed through the
review of clinical records and linkage to the mortality registries. During 4.8 years of follow-up, there
were 130 cancer deaths documented, evenly distributed across the levels of adherence to the score.
As a consequence, a nonsignificant association with cancer mortality was observed (HR high vs. very
low score = 0.66; 95% CI: 0.35–1.24). The estimated HRs were adjusted for age, gender, smoking,
physical activity, educational level, energy intake, and alcohol consumption. Additional adjustment
for anthropometric measures and medical history, or accounting for variations in dietary habits over
time, did not change the interpretation of the results.
Three different plant-based dietary indexes were evaluated in relation to cancer mortality in the
study by Baden et al. [53]. The purpose of this study was to examine whether changes in adherence to
these scores in 12 years were related to cancer mortality. A total of 75,314 men and women (mean age
= 63 years) from the Nurses’ Health Study (NHS) and the Health Professionals Follow-up Study
(HPFS) were followed-up for cancer deaths (N = 4263). Dietary data were collected every four years
with a validated semi-quantitative FFQ. The authors proposed an overall (standard) provegetarian
plant-based score, as well as healthier and unhealthier versions of this score. These scores were based
on the premise that plant-based foods have different diet quality, with foods such as fruit juices,
refined grains, potatoes, sugar-sweetened beverages, and sweets and desserts presumed to be less
healthy; whereas whole grains, fruits, vegetables, nuts, legumes, vegetable oils, tea, and coffee are
considered the opposite. All plant-based foods were scored positively, while all other foods scored
negatively. The change in adherence to the scores (at 8, 12, and 16 years) was evaluated in relation
to risk of cancer death. Cancer deaths in the cohorts were identified through mortality registries
and/or reported by the participant’s relatives. The authors found that an increase in adherence to the
provegetarian standard score (vs. stable adherence in 12 years) was associated with a lower risk of
cancer death. Concretely, 10 points increase in the adherence was associated with a 7% (95% CI: 2–11%)
decrease of cancer mortality risk. No consistent associations were observed between the other
provegetarian diet scores (healthy and unhealthy score) and overall cancer mortality in this study,
which was an unexpected finding since decreases in consumption of healthy plant foods were associated
with a higher risk of all-cause mortality. Neither were there statistically significant associations when
assessing the association between 12-year change in adherence to these scores with cause-specific
cancer mortality (lung, breast, and colon), except for prostate cancer (HR per 10 points increase in
adherence = 0.73; 95% CI: 0.55–0.96). Adjustment variables included many potential confounders
related with medical conditions, as well as body mass index (BMI).
It was not possible to meta-analyze the results of both studies due to differences in the assessment
of the adherence to the plant-based score, either at baseline [52] or over time [53]. The comparison
groups differed in both studies too, with regard to high vs. low adherence to the provegetarian diet
score [52], and change in adherence to the score vs. stable adherence over time [53]. None of the
studies accounted for cancer treatment or other prognostic factors.
3.3. Mediterranean Diet
Our literature search retrieved 13 studies on the association between the MD (either the original
MD scores (MDS), or its derivatives including the alternate MD (aMED), the modified MD (mMSD),
the MD pattern (MDP), or the relative Mediterranean diet (rMED) scores) and cancer mortality and
other related-outcomes [39–51]. Thus, the association between adherence to the MD and cancer
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mortality has been examined through five different a priori derived MD indexes. All studies were
cohort studies, considering validated dietary assessment tools to evaluate the adherence to the
MD, and all based the outcome assessment on reliable information sources (e.g., mortality and
cancer registries). All studies controlled for relevant confounders (age, sex, region, energy intake,
physical activity, education, and BMI), and several also considered comorbid conditions at baseline
for adjustment [40,50]. Interestingly, none of the studies on the association between MD diet and
overall cancer mortality risk controlled for prognostic-related factors in the analyses. More detailed
characteristics of these studies are shown in Table 3.
Among the studies analyzing the association between MDS adherence and cancer mortality
risk [39,41,43,46,48], two studies showed a statistically significant protective association [39,41],
but three studies did not support an association [43,46,59]. In this regard, Lassale et al. [39] studied
this association in the European Prospective Investigation into Cancer and Nutrition (EPIC) study
among 451,256 healthy participants, followed-up for 12.8 years. This study also evaluated adherence
to rMED, and both MDS and rMED (high vs. low adherence) were associated with a statistically
significant reduced overall cancer mortality risk (HR = 0.90; 95% CI: 0.88–0.92 and HR = 0.88; 95%
CI: 0.86–0.90, respectively). The study by Vormund et al. [41], which included 17,861 Swiss men and
women, also reported that a higher adherence to the MDS (vs. low) was associated with lower cancer
mortality risk in both men and women (HR = 0.95; 95% CI: 0.92–0.99), although this association was
stronger in men (HR = 0.92; 95% CI: 0.88–0.97) and absent in women. Furthermore, Lagiou et al. [43],
in a cohort of 42,237 Swiss women, showed that a one-point increase in the MDS was not significantly
associated with cancer mortality risk. On the other hand, a Spanish study conducted among 12,449 men
and women [46], found that MDS was not significantly associated with cancer mortality risk. As
for the MDP score, Cheng et al. [48] studied its association with cancer mortality risk within the
prospective Iowa Women’s Health Study from the USA, which included 35,221 cancer-free women
at baseline, of which 4665 died due to cancer during follow-up. The adjusted HR and 95% CI for
all-cancer mortality among participants in the highest relative to the lowest quintile was 0.93 (95% CI:
0.84–1.03).
The characteristics of other MD indexes, such as the aMED [40,44,45,47,49,51], the mMED [50],
and the rMED [39,42], are described in the original studies [30,63] and elsewhere [64]. In relation
to their association with cancer mortality and other outcomes, the following results were reported:
In general, the nine aMED studies suggested that high vs. low adherence to the aMED score was
associated with a decreased cancer mortality risk [40,44,45,47,49,51]. It should be noted that HR and
the corresponding 95% CIs were extracted from the figures in the study by Liese et al. [45]. This study
analyzed the association within three cohorts in a standardized manner. Overall, the study showed the
protective effects of the MD against cancer mortality. Two studies assessing the association with regard
to the mMED score were included [50]. A study by Warensjö et al. [50] of 38,428 Swedish women,
found that mMED was associated with a lower cancer mortality risk (HR high vs. low adherence = 0.81
95% CI: 0.69–0.94). Finally, the two rMED studies [39,42] showed diverging results: Lassale et al. [39]
showed a statistically significant inverse association with cancer mortality risk (HR = 0.88; 95% CI:
0.86–0.90) when considering the entire EPIC study cohort, whereas Buckland et al. [42] concluded that
a high compared with a low rMED score adherence was not associated with a significant reduction in
mortality from overall cancer in the Spanish EPIC cohort (HR = 0.92; 95% CI: 0.75–1.12).
Pooled estimates of the effect size and 95% CIs for cancer mortality risk comparing high vs. low
adherers to the MD (preferably for MDS and aMED) are depicted in Figure 2 and described below.
Distinctions by type of MD score were not made. Only overall mortality could be assessed due to
lack of studies on MD adherence and cancer-specific mortality (except one study on colorectal cancer
mortality). There was no evidence for publication bias according to the funnel plot and Egger test
(data not shown).
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Table 3. Characteristics of the studies evaluating the Mediterranean diet (high vs. low adherence) and cancer mortality including cause-specific cancer mortality.
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(Year) Country Study (Design)
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HR = hazard ratio; SD = standard deviation; F = females; M = males; FFQ = food frequency questionnaire; 24-HR = 24 h recall; CRC = colorectal cancer; NA = not available; n = number of
events; N = total population. Adjustments: 1: age; 2: smoking; 3: physical activity; 4: BMI; 5: education; 6: dietary score at baseline; 7: ethnicity; 8: total energy intake; 9: radiation
treatment; 10: pack-years; 11: chemotherapy; 12: nonsteroidal anti-inflammatory drug (NSAID) use; 13: family history of colorectal cancer; 14: comorbidities; 15: marital status; 16: alcohol
intake, 17: type 2 diabetes; 18: postmenopausal hormone replacement therapy; 19: race, 20: sex; 21: baseline examination year; 22: abnormal electrocardiogram; 23: dietary supplement use;
24: oral contraceptive use; 25: stage; 26: time since diagnosis; 27: age at first birth and parity; 28: menopausal status; 29: eeight change; 30: categories of treatment; 31: time between
diagnosis and completion of the questionnaire; 32: socioeconomic status; 33: self-reported prevalent chronic diseases at baseline; 34: moderate to vigorous physical activity; 35: diet score;
36: family history of cancer in a first-degree relative; 37: sleep duration; 38: history of hypertension; 39: living alone; 40: Charlson comorbidity index; 41: aspirin use, 42: changes in
smoking status; 43: family history of myocardial infarction; 44: family history of diabetes; 45: changes of physical activity; 46: changes in total energy intake; 47: weight change; 48: survey
wave; 49: region; 50: nationality; 53: waist circumference; 54: potato intake; 55: egg intake, 56: polyunsaturated lipid intake; 57: sweet intake; 58: non-alcoholic beverage intake.
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Figure 2. Meta-analysis under random-effects model (REM) with regard to adherers to the
Mediterranean diet (MD) (high vs. low) and overall cancer mortality. F = females, M = males.
3.3.1. Overall Cancer Mortality
We included eight studies comparing extreme groups (high vs. low) of adherence to the
MD [39,45,47–51]. There were two studies that did not report HR by these groups [41,43].
Moreover, the study by Buckland et al. [42] was also not considered for this meta-analysis due
to population overlap with the study of Lassale et al. [39]. In addition, the study by Liese contributed
only with women from the Women Health Initiative Observational Study (WHI-OS) [45]. The pooled
analyses (combining 74,267 cancer deaths among 1,949,146 persons) revealed that overall cancer
mortality risk was significantly reduced by 16% (95% CI: 11–30). However, there was significant
heterogeneity between the studies (I2 = 84%, p < 0.001), which disappeared after excluding the study
by Cuenca-Garcia et al. [46], while risk estimates remained the same.
3.3.2. Colorectal Cancer Mortality
The association between MD adherence and colorectal cancer mortality was assessed in one
study [40]. In this study, conducted within the Multiethnic Cohort Study (MEC) with 4204 colorectal
cancer events over follow-up and subsequent 1976 deaths (1095 were colorectal cancer-specific),
a nonsignificant association was observed between high vs. low adherence to aMED and colorectal
cancer mortality (HR = 0.90; 95% CI: 0.57–1.43). It is important to note that this was the only study
controlling for cancer treatment variables in the analyses.
3.4. Post-Diagnosis Studies on Plant-Based Dietary Patterns and Cancer Outcomes
We identified six studies on this topic based on our literature search [54–59], complemented with
studies included in previous reviews [11,12]. These studies were mostly focused on the MD as the
reference dietary pattern, or other predefined PBDPs. Included outcomes were both cancer mortality
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and recurrence. A summary of the studies on post-diagnosis PBDPs and cancer mortality is shown in
Table 4.
Of the selected studies, there was only one intervention study [57]. This study was conducted
within the Women’s Healthy Eating and Living (WHEL) Study, and included 3088 females with
non-metastatic breast cancer, who were randomized into an intervention and control group.
The intervention group received advice through telephone and cooking classes on how to adopt
the plant-based diet defined as a low-fat and high-fiber diet, characterized by a daily intake of five
vegetable servings, two glasses of vegetable juice, three fruit servings, 30 g of fiber, and 15% to 20%
of energy intake from fat. The control group received advice on maintaining a healthy diet only.
Compliance with the intervention was controlled through dietary records during the intervention
phase, which lasted six months. Consideration was given to potential confounding of the association
by prognostic factors of the disease, such as stage, and dietary habits at baseline. Results of this
study did not support that a plant-based diet is associated with a reduced risk of cancer death or
cancer recurrence. Although this was the only study available, the long follow-up, large sample size,
low residual confounding risk, and the adequacy of procedures during the intervention and follow-up,
makes the obtained results highly robust.
The remaining studies were cohort studies. Two of them were conducted within the NHS [54,55].
Both assessed the association between adherence to the MD by means of the alternate MD score
(aMED) and cancer mortality with regard to breast cancer [55] or colorectal cancer [54]. Early-stage
breast (N = 2729) and colorectal cancer (N = 1201) patients in these studies were females, who were
diagnosed with the disease during the follow-up of the cohort and were followed-up thereafter for
all-cause mortality and cancer cause-specific mortality. The cancer diagnosis and outcome was verified
by reviewing clinical records and death certificates. Adherence to aMED was assessed by the use of
the dietary information collected in two-yearly intervals with a FFQ. The aMED score, adapted from
the traditional MD Trichopolou score, awards one point for intakes higher than the population
median of vegetables, legumes, fruits, nuts, whole grains, fish, and monounsaturated:saturated
fat ratio, and intakes less than the median in meat, and in alcohol if intake is outside a given
range [64]. No statistically significant associations were found between high adherence to aMED
(vs. low adherence) and breast or colorectal cancer mortality in this study, nor did the authors
observe any association with regard to all-cause mortality in the breast or colorectal cancer survivors.
All estimates were adjusted for relevant prognostic factors of the disease (e.g., tumor stage, cancer
site, and treatment), as well as for the patient´s lifestyle or dietary habits before the cancer diagnosis.
Another American cohort study, conducted within the HPFS, addressed the association between
aMED and cancer mortality, particularly concerning prostate cancer mortality [58]. In this study, 4538
early-stage prostate cancer patients were followed-up since the cancer diagnosis until mortality or end
of follow-up. Comparable methods were applied to collect dietary information and to ascertain cancer
diagnosis and death. Likewise, by adjusting for prognostic factors of the disease and lifestyle/dietary
habits before the diagnosis, a significant inverse association was observed between high vs. low
adherence to the MD (both as aMED and MDS) and mortality from any cause (HR = 0.78; 95% CI:
0.67–0.90). However, statistical significance was not reached for mortality from prostate cancer.
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Table 4. Characteristics of the studies evaluating plant-based dietary patterns at post-diagnosis and cancer mortality and recurrence.
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F = females; M = males; FFQ = food frequency questionnaire; 24-HR = 24 h recall; CRC = colorectal cancer; NA = not available. Adjustments: 1: antiestrogen use; 2: oophorectomy
status; 3: tumor stage; 4: tumor site; 5: marital status; 6: age; 7: energy intake; 8: chemotherapy; 9: treatment; 10: smoking; 11: alcohol consumption; 12: multivitamin use; 13: physical
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replacement therapy; 31: Gleason score; 32: pre-diagnostic Mediterranean diet.
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Other post-diagnosis dietary indices that have been examined in relation to MD were the modified
Mediterranean diet score (mMDS) and the traditional Mediterranean diet score (MDS), which are
similar in their composition with respect to aMED [64]. The German PopGen Biobank Study [56],
which included 1404 colorectal cancer patients (histologically confirmed), among which 204 died
during six years of follow-up, reported that high vs. low adherence to the mMDS was associated
with a reduced all-cause mortality risk among those patients. The study accounted for the influence
of all possible prognostic factors and of pre-diagnostic adherence to the MD. Adherence to the MD
by the mMDS at pre- and post-diagnosis was assessed using dietary information collected via FFQs
administered in both time intervals. Lastly, within the National Health and Nutrition Examination
Survey (NHANES) study [59], 240 participants who self-reported a cancer diagnosis of breast or
gynecological cancers were followed-up during 10 years on average. Cancer mortality was assessed
by death certificates from clinical records and mortality registers. Dietary information collected with
a single 24 hour recall (HR) was used to score the participants into levels of adherence to the MDS.
This study showed that high vs. low adherence to this score was not significantly associated with
neither all-cause mortality nor breast cancer mortality.
It is worth noting that four of these studies also accounted for pre-diagnosis dietary information
on PBDPs [55,58,59,63], which was considered for the adjustment of baseline dietary intake in some of
these studies [58,63]. Only the study by Kim et al. [55] examined the effect of pre-diagnosis PBDPs
(aMED score) on cancer mortality among cancer survivors. As a result, no association was reported for
total mortality, breast cancer mortality, distant recurrences or non-breast cancer mortality.
Results of the meta-analyses of these studies by cancer site were only possible for breast and
colorectal cancer. No study evaluated the association between post-diagnosis PBDPs and cancer
mortality in relation to all-cause mortality. Publication bias was unlikely according to funnel plots and
Egger test.
3.4.1. Breast Cancer Mortality
Of the three studies evaluating an association between a PBDP and cancer mortality, there were
two cohort studies considering an MD score and breast cancer mortality [55,59]. The intervention
study was not considered for the meta-analysis due to its different nature. Pooled estimates for the
2849 breast cancer patients revealed that adherence to the MD (high vs. low) was not associated with
all-cause mortality among breast cancer survivors (RR = 0.87; 95% CI: 0.85–1.01). While heterogeneity
between the studies was not apparent (I2 = 0%, p = 1), the study by Karavisouglou contributed with
a small number of breast cancer patients, whose diagnoses were not confirmed [59]. Moreover, in this
study, breast and gynecological cancers were considered together, thus biasing the pooled analyses to
some extent. The other two studies provided more robust results [55,57], and supported that a PBDP
from breast cancer onset reduces all-cause or breast cancer mortality.
3.4.2. Colorectal Cancer Mortality
The studies by Fung [54] and Ratjen [56] were the only two studies available on the association
between PBDP and cancer mortality in colorectal cancer survivors. The MD was considered as
a plant-based pattern in both studies, either as aMED or mMDS. Together, these studies combined
the results of 2605 colorectal cancer patients. The summary estimates for all-cause mortality revealed
a nonsignificant association (HR = 0.66; 95% CI: 0.37–1.17); no other outcome events could be
analyzed due to lack of data. However, there was heterogeneity between both studies (I2 = 79%,
p = 0.03), possibly driven by differences inherent to the study populations (country of recruitment,
gender distribution, and clinical characteristics of the patients). It was not possible to examine the
influence of these variables on the pooled results.
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4. Discussion
The present review is the first to address the available evidence on the association between PBDPs
and cancer-related outcomes, including overall cancer mortality, cause-specific mortality, and cancer
recurrence. Plant-based diets have been traditionally regarded as vegetarian diets, but other definitions
of plant-based foods can be considered by rating negatively some or all animal foods, and even
accounting for the quality of plant-based foods in the diet. Only adherence of the MD was found to
reduce overall cancer mortality risk, but none of the studies accounted for the influence of prognostic
factors on this association; thus, the true independent effect of the MD with cancer mortality risk
remains inconclusive. Studies on other PBDPs in relation to these cancer outcomes have provided
nonsignificant or ambiguous results. The same was found for post-diagnostic studies on these
associations. Therefore, for the considered cancer-related outcomes, there is still insufficient evidence
for asserting that PBDPs help in reducing the risk of these outcomes.
Plant-based diets are dietary sources of several bioactive compounds such as fiber,
phenol, polyphenol, and sulfur compounds, and other antioxidants compounds including vitamins [7].
In the literature, foods of vegetable origin have been associated with cancer mortality outcomes,
although conflicting results have been reported. These include, for example, legumes [9],
fruits and vegetables [15], nuts [16], whole grains [16], and olive oil [18]. Bioactive compounds
in these foods, however, have been shown to have anti-carcinogenic effects in experimental models
and epidemiological studies [7]. For instance, high intake of fiber and polyphenols from cereals have
been shown to reduce cancer mortality risk [65–67]. As for cancer incidence, a two-tier mechanism
could explain how these compounds could prevent cancer mortality risk: first, fiber, mostly soluble
fiber, modulates the gut microbiota composition improving the colonic barrier functions, and second,
substrates such as resistant starch, non-starch polysaccharides (β-glucans), and phenols are metabolized
into active metabolites by the commensal microbiota [68]. The resulting metabolites have well known
anti-cancer effects and could likewise prevent cancer mortality. For instance, phenolic acids are
antioxidants with free-radical scavenging activity. Free radicals play an important role not only for
cancer development but also in cancer treatment since anti-cancer drugs generate reactive oxygen
species themselves [69]. Therefore, neutralizing their damaging effects is crucial to reduce mortality
and secondary outcomes in cancer patients. Other metabolites, such as short-chain fatty acids are
also major players in the maintenance of gut integrity and immune homeostasis, to prevent tumor
development [68].
The drawbacks of individual nutrient or foods studies have been repeatedly described [19].
PBDPs or indexes based on the potential beneficial effects of various dietary factors, and accounting
for the interaction of all phytochemicals contained in the diet, should be therefore a better approach to
examine the association between plant-based diets and cancer mortality. PBDPs have been related
to a low-risk immunological profile (lower C-reactive protein, fibrinogen, and leukocyte levels) [70],
lower adiposity markers [62], and better antioxidant status [71]. These are probably the underlying
mechanisms by which these diets could improve the immune response in cancer patients, while also
slowing tumor growth and risk of developing subsequent events.
Vegetarian diets are based on the consumption of plant-based foods, namely vegetables,
fruits, whole grains, legumes, nuts, and seeds, with the elimination of foods of animal origin such as
meat, poultry, wild game, seafood, and their byproducts [72]. In a narrower sense, vegetarian diets
may or may not include eggs and dairy products. Vegan diets, for instance, exclude these dietary
factors, whereas lacto-, ovo-, and lacto-ovo vegetarians include either dairy products, or eggs and egg
products, or both dairy products and eggs, respectively. Vegetarian diets comply with healthy diet
recommendations and are therefore considered a healthful dietary pattern [72]. A negative side of
this dietary pattern is the potential deficient intake of certain nutrients such as iron and vitamin B12.
Long-chain n-3 fatty acids, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), are lower
in vegetarians and typically absent in vegans [73]. Decreased intakes of some of these nutrients have
been related to a higher cancer incidence in some studies [74]. On the contrary, the reduced intake of
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heme-iron in vegetarians is presumed to be beneficial taking into consideration that high ferritin levels
due to iron overload have been related to a higher risk of certain cancers [75]. However, it is considered
that if vegetarian diets are well-planned, their naturally high content of beneficial bioactive compounds
outweigh the negative sides [72,76]. Indeed, it has been reported that vegetarians have a lower
cancer incidence than nonvegetarians [26], or at least regarding colorectal cancer for semi-vegetarians
or pesco-vegetarians compared to nonvegetarians [77]. While the results of our review tended to
suggest that vegetarians and vegans have a lower risk of cancer mortality and cancer-specific mortality
when compared to nonvegetarians, we did not observe significant associations in meta-analyses
combining results of the selected studies. By updating a previous review examining vegetarian diets
regarding several health issues [26], we provide more consistent data, although it is still insufficient to
provide meaningful conclusions. Indeed, vegetarians do not make up large population groups and
are therefore difficult to ascertain in epidemiological studies. Moreover, as shown in the study by
Key et al. [60], vegetarians or vegans often adopt a healthier lifestyle (e.g., non-smoking) as compared
to omnivores, making it more difficult to establish comparisons between both groups. The sample size
of the included studies was too limited to permit overall and cause-specific cancer mortality studies.
Another important aspect as to why we probably did not observe a significant overall effect might
be due to different considerations of vegetarians, vegans, and type of vegetarian diets among the
studies. Based on the responses to a finite list of foods, participants were classified into vegetarians and
vegans in most studies; only the study by Orlich based this classification upon a validated FFQ [61].
Misclassification of vegetarian diets was therefore likely in these studies. In addition, it was not
possible to make any comparisons with regard to type of vegetarian diet since few studies attempted
to link the type of diet with cancer mortality risk [38]. Thus, for example, whether pesco-vegetarian or
lacto-vegetarian diets, rich in dietary factors with colorectal cancer prevention potential (e.g., calcium,
fiber, n-3 fatty acids, and vitamin antioxidants), have a stronger prevention effect against mortality of
this disease could not be confirmed.
Recently, a priori-defined plant-based scores have been proposed to allow comparisons between
different levels of compliance with vegetable-derived foods against animal-derived foods [53].
Provegetarian food pattern scores are newly developed tools to assess the level of adherence to
a vegetarian-like diet (i.e., preference of plant-based foods). Unlike the vegetarian dietary patterns,
these scores consider moderate intakes of animal foods such as fish, poultry, and dairy in the
assessment of the score, under the assumption that moderate intake of these foods may confer some
health benefits [78–80]. Moreover, in this manner, these scores are presumed to overcome the potential
nutrient intake deficiencies (e.g., vitamin B12), that a strict plant-based diet such as the vegetarian diet
poses. Accordingly, they score vegetable-derived foods positively, while all animal-derived foods are
scored negatively. However, with only two studies evaluating how these scores affect cancer mortality
risk [52,53], it has been difficult to arrive at any concrete conclusion. The time point considered for
the assessment of the provegetarian diet differed in both studies. Furthermore, both studies were not
comparable in the sense that the provegetarian diet score was not defined in the same way. While both
considered all animal foods, only the study by Baden et al. [53] distinguished the quality of plant-based
foods in the scoring. This study reported associations for a standard provegetarian diet score, and for
its healthy and unhealthy versions. Relative to the unhealthy score, the healthy one scored more
negatively foods rich in refined carbohydrates, which are supposed to be implicated in cancer risk
through energy metabolism, insulin, and insulin-like growth factor (IGF-1) upregulations. A major
impact of the healthy provegetarian diet score for cancer mortality prevention was therefore expected.
Nevertheless, significant associations were only observed for the standard score.
The MD encompasses the traditional dietary pattern found in the olive-growing regions of the
Mediterranean basin in the 1960s [81], and is globally recognized as a healthy dietary model [82].
The traditional MD pattern is a well-defined plant-based dietary pattern characterized by: the daily
use of olive oil; an abundance of plant foods such as fruits and vegetables, nuts and seeds, cereals and
legumes; the consumption of fish and seafood especially in coastal regions; moderate-to-low intake of
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dairy products mostly from fresh cheese and yogurt; moderate alcohol mostly in the form of wine; and
a less frequent consumption of meat and meat products [83]. Thus, the MD pattern is distinctively
plant-based, and thus a valuable alternative to the vegetarian diet, as it provides a good supply of
fiber, phytochemicals, vitamins, and minerals, even closing some nutritional gaps of the vegetarian
diet [83]. For the reasons cited above, we considered the MD as a reference PBDP. Moreover, the MD is
presumed to boost the endogenous antioxidant defense and the immune system to prevent cancer and,
possibly, also fatal outcomes of this disease. With respect to cancer incidence, indeed, as is also the
case with other dietary patterns, the MD is an established dietary pattern for cancer prevention [13,84].
Other dietary patterns resembling plant-based diets such as the very low ketogenic diet, seem to have
cancer prevention potential through weight loss and related mechanisms, but have been scarcely
examined with regard to cancer mortality [85].
Since the first definition of an MD index, multiple adaptations have been created to improve
its conformity to the MD [64]. The MD scores used to assess the association between the MD and
cancer mortality risk are the MDS, MDP, rMED, and aMED. Pooled analyses of the included studies
revealed a significant inverse association between high vs. low adherence to the MD and overall cancer
mortality risk. While we combined the studies regardless of the MD score, it has been reported that
there is only moderate concordance between them [86]. Indeed, MD scores vary largely in the types of
foods included and the intake levels in the population. Thus, variability in the scoring schemes of the
MD scores might have affected our results. However, when restricting our meta-analysis to studies
using the MDS (the predominant score), the result was maintained (data not shown). Despite the fact
that our results support a beneficial effect of the MD for the prevention of cancer mortality, we have to
be cautious in the interpretation of these results. No study considered the influence of relevant factors
related with the disease outcomes, such as treatment, on the associations. In addition, there was scarce
data on the association between MD and cancer mortality by type of cancer.
As outlined before, most of the studies on the association between PBDPs and cancer
mortality considered the influence of such diets from pre-diagnosis states to the event outcomes.
However, post-diagnosis diet might have a strong short-term or even long-term effect on cancer
mortality and other related outcomes. Whether eating a PBDP after cancer diagnosis affects cancer
outcomes has been addressed in several studies. Although these studies accounted for a large number
of factors related to the outcome (all potential prognostic factors: clinical and pathological tumor
characteristics, treatment, and comorbidities), their results must be interpreted with caution due to the
limited sample sizes. Moreover, there was only one intervention study on the effect of a well-defined
plant-based diet on cancer-related outcomes [57]. Importantly, this study did not address whether
consuming the high vegetable/fruit/fiber and low-fat diet of the study intervention early in life would
alter the risk of breast cancer and cancer mortality as well. The remaining studies were cohort
studies assessing the association between adherence to the MD since the cancer diagnosis and cancer
mortality [34–56,58,59]. Some [34–53], but not all [54–59], of the included studies also accounted for
dietary behaviors before the cancer onset. In fact, as this review shows, dietary patterns over a lifetime
are likely to influence cancer mortality. Future studies on the association between PBDPs and cancer
mortality should therefore consider assessing adherence to PBDPs throughout the lifespan, to cover
pre- and post-diagnostic influences of these dietary patterns on the associations.
Thus, while dietary patterns have been consistently associated with a reduction of cancer incidence,
an association with cancer mortality has not been clearly established. This contradiction could be
explained by the fact that cancer mortality is greatly influenced by the type and treatment regime.
Indeed, cohort studies assessing the association from a pre-diagnosis state typically did not account for
this factor. Rather, this was accounted for in studies evaluating how adherence to these plant-based
diets since diagnosis impacts on these outcomes. On the other hand, the lack of statistical power
to detect significant associations in cause-specific mortality studies is another important limiting
factor that makes it impossible to draw any meaningful conclusions on this association. In fact,
there are no studies on cause-specific cancer mortality other than lung cancer, breast cancer, colon
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cancer, and prostate cancer. Also of note, is the fact that studies on other cancer-related outcomes,
such as secondary cancers, are unavailable. No study considered the interaction between dietary and
genetic factors on these associations. Most studies relied on a single measurement of diet at baseline,
but dietary patterns may change over time and the length of exposure to plant-based-like dietary
patterns may account for the differences observed between results from different cohorts. Dietary
assessment tools (3-day records, 24-h recalls or FFQs) also differed greatly between the studies, as
well as the studied populations. For instance, there were both pre and postmenopausal breast cancer
patients considered jointly in some studies. Moreover, while the definitions of vegetarians and vegans
were well-defined, some studies seemed to mix up vegans and vegetarians. Further, in the case of the
comparison groups, there were differences among the studies with regard to the definition of meat
eaters (omnivores). The included studies considered either populations of adherers to a specific PBDP
(for example, vegans and vegetarians) or cohorts with individuals classified into different levels of
adherence to PBDPs (for example, MD adherence groups) according to their reported dietary data.
Therefore, the possibility that some studies misclassified vegetarians, vegans or adherence to other
types of plant-based diets cannot be ruled out. Finally, plant-based diets contain a huge variability
of bioactive compounds depending on the dietary source, which makes the definition of a healthy
plant-based diet particularly complex. Among the limitations of this review, there were also issues
related to population overlap in the vegetarian studies [35,38], which could have introduced bias to
our results. We could also not analyze whether duration of adherence to any PBDP had any influence
on the results.
There are also strengths of this review worthy of consideration: this is the first review and
meta-analysis that has analyzed all the available data on PBDPs in relation to cancer mortality and
related outcomes. While a rapid review was conducted, we complemented the identification of studies
with those included in other reviews related to our topic. However, a quality assessment of these
studies was not performed. We were able to conduct analyses by some cancer types and to evaluate
the influence of some study characteristics on the results. However, we were not able to meta-analyze
studies according to all cancer types due to lack of studies.
5. Conclusions
This review and meta-analysis of the current available evidence on the association between PBDPs
and cancer mortality show that there is limited evidence regarding the beneficial effects of vegetarian
diets for the prevention of cancer-related outcomes in the general population and in cancer survivors.
This review also shows that there is suggestive evidence regarding the association between the MD
pattern and cancer mortality. There were very few studies evaluating how these dietary patterns
influence cancer mortality after the cancer diagnosis. Breast cancer and colorectal cancer outcomes
were by far the most studied cancer types, but the number of studies is small. Thus, there is an urgent
need to increase our knowledge on the usefulness of plant-based diets for the prevention of cancer
mortality. Well-designed studies, considering consensus definitions of PBDPs and all pertinent factors
including prognostic factors of the disease, genomics, and others, are needed to determine the effect of
plant-based diets on cancer survival and cancer recurrence, before and after the diagnosis of cancer.
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Appendix A
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